United States

People: Cerner Corp (CERN.OQ)

CERN.OQ on NASDAQ Stock Exchange Global Select Market

23 Jun 2017
Change (% chg)

$0.98 (+1.46%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bisbee, Gerald 

Dr. Gerald E. Bisbee, Jr., Ph.D., is Independent Director of Cerner Corporation. Dr. Bisbee has been a Director of the Company since February 1988. Dr. Bisbee is the co-founder, Chairman and Chief Executive Officer of The Health Management Academy, which provides leadership development and advisory services for senior executives of the country's largest health systems and corporations and facilitates the exchange of best practices and benchmarking data, focused on increasing the quality, appropriateness and efficiency of care. From 1998 to September 2011, Dr. Bisbee was President, Chief Executive Officer and Chairman of the Board of Directors of ReGen Biologics, Inc. ("ReGen"), which developed, manufactured and marketed orthopedic tissue repair products worldwide. Dr. Bisbee was President, Chief Executive Officer and a Director of Aros Corporation (formerly known as APACHE Medical Systems, Inc.) commencing in December 1989, serving as Chairman of the Board from December 1989 to November 1997 and from December 2000 to June 2002, when ReGen and Aros Corporation merged. ReGen filed for protection under Chapter 11 of the United States Bankruptcy Code in April 2011 and substantially all of the business and assets of ReGen were purchased by Sports Medicine Holdings Company, LLC in June 2011. Prior to 1989, Dr. Bisbee was Director of the Healthcare Group at Kidder, Peabody & Co., President of the Hospital Research and Educational Trust (the research and development arm of the American Hospital Association), and a faculty member in graduate management programs at Yale University and Northwestern University.

Basic Compensation

Total Annual Compensation, USD 98,500
Restricted Stock Awards, USD 254,288
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 352,788

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Neal Patterson


Zane Burke


Clifford Illig


Marc Naughton


Michael Nill


Jeffrey Townsend

As Of  1 Jan 2017